Actelion Pharmaceuticals Ltd

General

Total Cases35

Active Cases2

Patents122

CourtsD. New Jersey D. Delaware E.D. Virginia

TypeOperating Company

Elite Ratings

DCT

actelion-pharmaceuticals

Ratings

Experience

Grade

Trend

DCT

L5

A

PTAB

L5

E

CAFC

L5

E

Analytics

Cases

Litigated Patents

Ratings Trends

Recent Dockets

Entered	Case	Description
11/01/24	Actelion Pharmaceuticals Ltd v. Gland Pharma Ltd 1:24-CV-00434 ( D. DE )	DECLARATION re [33] Opening Brief in Support, of Charles K. Shih by Gland Pharma Limited. (Attachments: # [1] Exhibit 1, # [2] Exhibit 2, # [3] Exhibit 3, # [4] Exhibit 4, # [5] Exhibit 5)(Gattuso, Dominick) (Entered: 11/01/2024)
11/01/24	Actelion Pharmaceuticals Ltd v. Gland Pharma Ltd 1:24-CV-00434 ( D. DE )	[SEALED] OPENING BRIEF in Support re [32] MOTION for Judgment on the Pleadings , [31] MOTION to Seal Defendant Gland Pharma Limited's Unopposed Motion for Leave to File Its Opening Brief in Support of Its Motion For Judgment on the Pleadings Pursuant to Fed. R. Civ. P. 12(C) Under Seal filed by Gland Pharma Limited.Answering Brief/Response due date per Local Rules is 11/15/2024. (Attachments: # [1] Certificate of Service)(Gattuso, Dominick) (Entered: 11/01/2024) [SEALED] OPENING BRIEF in Support re [32] MOTION for Judgment on the Pleadings , [31] MOTION to Seal Defendant Gland Pharma Limited's Unopposed Motion for Leave to File Its Opening Brief in Support of Its Motion For Judgment on the Pleadings Pursuant to Fed. R. Civ. P. 12(C) Under Seal filed by Gland Pharma Limited.Answering Brief/Response due date per Local Rules is 11/15/2024. (Attachments: # [1] Certificate of Service)(Gattuso, Dominick) (Entered: 11/01/2024)
11/01/24	Actelion Pharmaceuticals Ltd v. Gland Pharma Ltd 1:24-CV-00434 ( D. DE )	MOTION for Judgment on the Pleadings - filed by Gland Pharma Limited. (Attachments: # [1] Text of Proposed Order)Motions referred to Christopher J. Burke.(Gattuso, Dominick) (Entered: 11/01/2024)
11/01/24	Actelion Pharmaceuticals Ltd v. Gland Pharma Ltd 1:24-CV-00434 ( D. DE )	MOTION to Seal Defendant Gland Pharma Limited's Unopposed Motion for Leave to File Its Opening Brief in Support of Its Motion For Judgment on the Pleadings Pursuant to Fed. R. Civ. P. 12(C) Under Seal - filed by Gland Pharma Limited. (Attachments: # [1] Text of Proposed Order, # [2] Rule 7.1.1 Statement)Motions referred to Christopher J. Burke.(Gattuso, Dominick) (Entered: 11/01/2024)
11/01/24	Actelion Pharmaceuticals Ltd v. Bristol Myers Squibb Co 2:21-CV-18695 ( D. NJ )	Please be advised that this entry is being made for statistical reporting purposes only re D.E. 192 Text Order. (ams, ) (Entered: 11/01/2024)
11/01/24	Actelion Pharmaceuticals Ltd v. Bristol Myers Squibb Co 2:21-CV-18695 ( D. NJ )	Please be advised that this entry is being made for statistical reporting purposes only re D.E. 192 Text Order. (ams, ) (Entered: 11/01/2024)
10/31/24	Actelion Pharmaceuticals Ltd v. Bristol Myers Squibb Co 2:21-CV-18695 ( D. NJ )	TEXT ORDER - The telephone conference set for November 12, 2024 before Magistrate Judge Leda D. Wettre is adjourned to January 23, 2025 at 4:00 p.m. The parties shall submit concise status letters to the Court no later than one week in advance of the conference. Dial-in information for the conference is (973) 437-5535, access code 850 795 61#. So Ordered by Magistrate Judge Leda D. Wettre on 10/31/2024. (rn) (Entered: 10/31/2024) TEXT ORDER - The telephone conference set for November 12, 2024 before Magistrate Judge Leda D. Wettre is adjourned to January 23, 2025 at 4:00 p.m. The parties shall submit concise status letters to the Court no later than one week in advance of the conference. Dial-in information for the conference is (973) 437-5535, access code 850 795 61#. So Ordered by Magistrate Judge Leda D. Wettre on 10/31/2024. (rn) (Entered: 10/31/2024)
10/31/24	Actelion Pharmaceuticals Ltd v. Bristol Myers Squibb Co 2:21-CV-18695 ( D. NJ )	TEXT ORDER - The telephone conference set for November 12, 2024 before Magistrate Judge Leda D. Wettre is adjourned to January 23, 2025 at 4:00 p.m. The parties shall submit concise status letters to the Court no later than one week in advance of the conference. Dial-in information for the conference is (973) 437-5535, access code 850 795 61#. So Ordered by Magistrate Judge Leda D. Wettre on 10/31/2024. (rn) (Entered: 10/31/2024) TEXT ORDER - The telephone conference set for November 12, 2024 before Magistrate Judge Leda D. Wettre is adjourned to January 23, 2025 at 4:00 p.m. The parties shall submit concise status letters to the Court no later than one week in advance of the conference. Dial-in information for the conference is (973) 437-5535, access code 850 795 61#. So Ordered by Magistrate Judge Leda D. Wettre on 10/31/2024. (rn) (Entered: 10/31/2024)
10/30/24	Actelion Pharmaceuticals Ltd v. Bristol Myers Squibb Co 2:21-CV-18695 ( D. NJ )	TEXT ORDER - This matter is hereby referred to mediation and is administratively terminated pending completion of mediation. The Court shall communicate with the parties as to the selection of the mediator. So Ordered by Judge Claire C. Cecchi on 10/30/2024. (jl, ) (Entered: 10/30/2024)
10/30/24	Actelion Pharmaceuticals Ltd v. Bristol Myers Squibb Co 2:21-CV-18695 ( D. NJ )	TEXT ORDER - This matter is hereby referred to mediation and is administratively terminated pending completion of mediation. The Court shall communicate with the parties as to the selection of the mediator. So Ordered by Judge Claire C. Cecchi on 10/30/2024. (jl, ) (Entered: 10/30/2024)